Hou Pengwei, Liu Meiyan, Li Ziqi, Cai Mingfa, Cai Chenzhu
Department of Neurosurgery, Shanghai Sixth People's Hospital Fujian, Jinjiang, Fujian 362200, P.R. China.
Department of Hepatology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian 350025, P.R. China.
Oncol Lett. 2025 May 14;30(1):343. doi: 10.3892/ol.2025.15089. eCollection 2025 Jul.
Glioblastoma (GBM) is the most common type of primary malignant brain tumor. Extracranial metastasis (ECM) is rare and usually indicates poor prognosis. We report a case of a 31-year-old female with GBM who underwent gross total resection followed by standard chemoradiotherapy. For recurrence, she received tumor treating fields and bevacizumab. At 23 months post-surgery, she developed COVID-19 pneumonia treated with dexamethasone, followed by spinal symptoms. MRI revealed L1-L2 lesions, and pathology after lumbar surgery confirmed ECM. Despite further treatment, the patient died of respiratory failure at 28 months. The present case illustrates the aggressive nature of ECM in GBM and the limited efficacy of current therapies in metastatic settings. Surgical resection and chemoradiotherapy remain the mainstay, while emerging treatments may provide hope for recurrent cases. Supportive care plays a critical role in advanced disease stages.
胶质母细胞瘤(GBM)是最常见的原发性恶性脑肿瘤类型。颅外转移(ECM)较为罕见,通常提示预后不良。我们报告了一例31岁的胶质母细胞瘤女性患者,该患者接受了全切除手术,随后进行了标准的放化疗。复发后,她接受了肿瘤电场治疗和贝伐单抗治疗。术后23个月,她患上了COVID-19肺炎,接受了地塞米松治疗,随后出现脊髓症状。磁共振成像(MRI)显示L1-L2节段有病变,腰椎手术后的病理检查证实为颅外转移。尽管进行了进一步治疗,患者在28个月时死于呼吸衰竭。本病例说明了胶质母细胞瘤中颅外转移的侵袭性以及当前治疗方法在转移性情况下的疗效有限。手术切除和放化疗仍然是主要治疗手段,而新兴治疗方法可能为复发病例带来希望。支持性治疗在疾病晚期起着关键作用。